XENON PHARMACEUTICALS INC. Net Income
XENON PHARMACEUTICALS INC. (XENE) reported Net Income of -$110.74 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-06
- XENON PHARMACEUTICALS INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$110.74M.
- XENON PHARMACEUTICALS INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$102.30M.
- XENON PHARMACEUTICALS INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$105.26M.
- XENON PHARMACEUTICALS INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$90.90M.
- XENON PHARMACEUTICALS INC. net income (loss) attributable to parent for fiscal 2020 was -$28.84M.
- XENON PHARMACEUTICALS INC. net income (loss) attributable to parent for fiscal 2019 was -$41.59M.
- XENON PHARMACEUTICALS INC. net income (loss) attributable to parent for fiscal 2018 was -$34.50M.
- XENON PHARMACEUTICALS INC. net income (loss) attributable to parent for fiscal 2017 was -$30.70M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$110.74M 10-Q · filed 2026-08-06 | -$213.04M 10-Q · filed 2026-08-06 | -$318.30M derived: sum of 3 quarters · filed 2026-08-06 | -$409.19M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$102.30M 10-Q · filed 2026-08-06 | -$207.56M derived: sum of 2 quarters · filed 2026-08-06 | -$298.46M derived: sum of 3 quarters · filed 2026-08-06 | -$383.17M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$105.26M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | -$196.16M derived: sum of 2 quarters · filed 2026-04-22 | -$280.86M derived: sum of 3 quarters · filed 2026-08-06 | -$345.91M DEF 14A · filed 2026-04-22 | |
| 2025-09-30 | -$90.90M 10-Q · filed 2025-11-03 | -$175.60M derived: sum of 2 quarters · filed 2026-08-06 | -$240.65M 10-Q · filed 2025-11-03 | -$306.33M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$84.71M 10-Q · filed 2026-08-06 | -$149.75M 10-Q · filed 2026-08-06 | -$215.44M derived: sum of 3 quarters · filed 2026-08-06 | -$278.23M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$65.05M 10-Q · filed 2026-08-06 | -$130.73M derived: sum of 2 quarters · filed 2026-08-06 | -$193.52M derived: sum of 3 quarters · filed 2026-08-06 | -$251.45M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-12-31 | -$65.69M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | -$128.47M derived: sum of 2 quarters · filed 2026-04-22 | -$186.40M derived: sum of 3 quarters · filed 2026-04-22 | -$234.33M DEF 14A · filed 2026-04-22 | |
| 2024-09-30 | -$62.79M 10-Q · filed 2025-11-03 | -$120.71M derived: sum of 2 quarters · filed 2025-11-03 | -$168.65M 10-Q · filed 2025-11-03 | -$213.39M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2024-06-30 | -$57.92M 10-Q · filed 2025-11-03 | -$105.86M 10-Q · filed 2025-08-11 | -$150.60M derived: sum of 3 quarters · filed 2026-04-22 | -$199.06M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2024-03-31 | -$47.93M 10-Q · filed 2025-11-03 | -$92.67M derived: sum of 2 quarters · filed 2026-04-22 | -$141.14M derived: sum of 3 quarters · filed 2026-04-22 | -$188.60M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2023-12-31 | -$44.74M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | -$93.20M derived: sum of 2 quarters · filed 2026-04-22 | -$140.67M derived: sum of 3 quarters · filed 2026-04-22 | -$182.39M DEF 14A · filed 2026-04-22 | |
| 2023-09-30 | -$48.46M 10-Q · filed 2024-11-12 | -$95.92M derived: sum of 2 quarters · filed 2024-11-12 | -$137.65M 10-Q · filed 2024-11-12 | -$175.04M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2023-06-30 | -$47.46M 10-Q · filed 2024-11-12 | -$89.19M 10-Q · filed 2024-08-08 | -$126.58M derived: sum of 3 quarters · filed 2026-04-22 | -$163.73M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2023-03-31 | -$41.73M 10-Q · filed 2024-11-12 | -$79.12M derived: sum of 2 quarters · filed 2026-04-22 | -$116.27M derived: sum of 3 quarters · filed 2026-04-22 | -$147.43M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2022-12-31 | -$37.40M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | -$74.55M derived: sum of 2 quarters · filed 2026-04-22 | -$105.70M derived: sum of 3 quarters · filed 2026-04-22 | -$125.37M DEF 14A · filed 2026-04-22 | |
| 2022-09-30 | -$37.15M 10-Q · filed 2023-11-08 | -$68.31M derived: sum of 2 quarters · filed 2023-11-08 | -$87.98M 10-Q · filed 2023-11-08 | -$113.54M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2022-06-30 | -$31.16M 10-Q · filed 2023-11-08 | -$50.83M 10-Q · filed 2023-08-09 | -$76.39M derived: sum of 3 quarters · filed 2026-04-22 | -$91.84M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2022-03-31 | -$19.67M 10-Q · filed 2023-11-08 | -$45.23M derived: sum of 2 quarters · filed 2026-04-22 | -$60.68M derived: sum of 3 quarters · filed 2026-04-22 | -$82.79M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2021-12-31 | -$25.56M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | -$41.01M derived: sum of 2 quarters · filed 2026-04-22 | -$63.12M derived: sum of 3 quarters · filed 2026-04-22 | -$78.88M DEF 14A · filed 2026-04-22 | |
| 2021-09-30 | -$15.45M 10-Q · filed 2022-11-08 | -$37.55M derived: sum of 2 quarters · filed 2022-11-08 | -$53.32M 10-Q · filed 2022-11-08 | -$65.64M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$22.11M 10-Q · filed 2022-11-08 | -$37.87M 10-Q · filed 2022-08-09 | -$50.20M derived: sum of 3 quarters · filed 2023-03-01 | -$59.05M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | -$15.76M 10-Q · filed 2022-11-08 | -$28.09M derived: sum of 2 quarters · filed 2023-03-01 | -$36.94M derived: sum of 3 quarters · filed 2023-03-01 | -$37.12M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$12.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$21.18M derived: sum of 2 quarters · filed 2023-03-01 | -$21.35M derived: sum of 3 quarters · filed 2023-03-01 | -$28.84M 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$8.86M 10-Q · filed 2021-11-10 | -$9.03M derived: sum of 2 quarters · filed 2021-11-10 | -$16.51M 10-Q · filed 2021-11-10 | -$27.89M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$175.00K 10-Q · filed 2021-11-10 | -$7.66M 10-Q · filed 2021-08-11 | -$19.04M derived: sum of 3 quarters · filed 2021-11-10 | -$27.91M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-03-31 | -$7.48M 10-Q · filed 2021-11-10 | -$18.86M derived: sum of 2 quarters · filed 2021-11-10 | -$27.73M derived: sum of 3 quarters · filed 2021-11-10 | -$37.74M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2019-12-31 | -$11.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$20.25M derived: sum of 2 quarters · filed 2021-03-01 | -$30.25M derived: sum of 3 quarters · filed 2021-03-01 | -$41.59M 10-K · filed 2021-03-01 | |
| 2019-09-30 | -$8.87M 10-Q · filed 2020-11-05 | -$18.88M derived: sum of 2 quarters · filed 2020-11-05 | -$30.22M 10-Q · filed 2020-11-05 | -$38.78M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | -$10.01M 10-Q · filed 2020-11-05 | -$21.35M 10-Q · filed 2020-08-06 | -$29.91M derived: sum of 3 quarters · filed 2020-11-05 | -$44.29M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-03-31 | -$11.34M 10-Q · filed 2020-11-05 | -$19.90M derived: sum of 2 quarters · filed 2020-11-05 | -$34.28M derived: sum of 3 quarters · filed 2020-11-05 | -$42.08M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2018-12-31 | -$8.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$22.94M derived: sum of 2 quarters · filed 2020-03-09 | -$30.74M derived: sum of 3 quarters · filed 2020-03-09 | -$34.50M 10-K · filed 2020-03-09 | |
| 2018-09-30 | -$14.38M 10-Q · filed 2019-11-05 | -$22.18M derived: sum of 2 quarters · filed 2019-11-05 | -$25.94M 10-Q · filed 2019-11-05 | -$34.00M derived: sum of 4 quarters · filed 2019-11-05 | |
| 2018-06-30 | -$7.80M 10-Q · filed 2019-11-05 | -$11.56M 10-Q · filed 2019-08-06 | -$19.62M derived: sum of 3 quarters · filed 2019-11-05 | -$27.36M derived: sum of 4 quarters · filed 2019-11-05 | |
| 2018-03-31 | -$3.75M 10-Q · filed 2019-11-05 | -$11.82M derived: sum of 2 quarters · filed 2019-11-05 | -$19.56M derived: sum of 3 quarters · filed 2019-11-05 | -$26.94M derived: sum of 4 quarters · filed 2019-11-05 | |
| 2017-12-31 | -$8.06M 10-K · filed 2018-03-07 | -$15.81M derived: sum of 2 quarters · filed 2018-11-06 | -$23.19M derived: sum of 3 quarters · filed 2018-11-06 | -$30.70M 10-K · filed 2019-03-06 | |
| 2017-09-30 | -$7.74M 10-Q · filed 2018-11-06 | -$15.12M derived: sum of 2 quarters · filed 2018-11-06 | -$22.64M 10-Q · filed 2018-11-06 | -$28.64M derived: sum of 4 quarters · filed 2018-11-06 | |
| 2017-06-30 | -$7.38M 10-Q · filed 2018-08-07 | -$14.90M 10-Q · filed 2018-08-07 | -$20.90M derived: sum of 3 quarters · filed 2018-08-07 | -$28.61M derived: sum of 4 quarters · filed 2018-08-07 | |
| 2017-03-31 | -$7.52M 10-Q · filed 2018-05-08 | -$13.52M derived: sum of 2 quarters · filed 2018-05-08 | -$21.23M derived: sum of 3 quarters · filed 2018-05-08 | -$27.25M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | -$6.00M 10-K · filed 2018-03-07 | -$13.72M derived: sum of 2 quarters · filed 2018-03-07 | -$19.73M derived: sum of 3 quarters · filed 2018-03-07 | -$23.00M 10-K · filed 2018-03-07 | |
| 2016-09-30 | -$7.71M 10-K · filed 2018-03-07 | -$13.73M derived: sum of 2 quarters · filed 2018-03-07 | -$16.99M 10-Q · filed 2017-11-07 | -$20.93M derived: sum of 4 quarters · filed 2018-03-07 | |
| 2016-06-30 | -$6.02M 10-K · filed 2018-03-07 | -$9.28M 10-Q · filed 2017-08-03 | -$13.22M derived: sum of 3 quarters · filed 2018-03-07 | -$17.04M derived: sum of 4 quarters · filed 2018-03-07 | |
| 2016-03-31 | -$3.26M 10-K · filed 2018-03-07 | -$7.20M derived: sum of 2 quarters · filed 2018-03-07 | -$11.03M derived: sum of 3 quarters · filed 2018-03-07 | -$9.86M derived: sum of 4 quarters · filed 2018-03-07 | |
| 2015-12-31 | -$3.94M 10-K · filed 2017-03-08 | -$7.76M derived: sum of 2 quarters · filed 2017-03-08 | -$6.60M derived: sum of 3 quarters · filed 2017-03-08 | -$15.75M 10-K · filed 2018-03-07 | |
| 2015-09-30 | -$3.83M 10-K · filed 2017-03-08 | -$2.66M derived: sum of 2 quarters · filed 2017-03-08 | -$11.81M 10-Q · filed 2016-11-03 | -$10.59M derived: sum of 4 quarters · filed 2017-03-08 | |
| 2015-06-30 | $1.17M 10-K · filed 2017-03-08 | -$7.99M 10-Q · filed 2016-08-03 | -$6.76M derived: sum of 3 quarters · filed 2017-03-08 | $2.43M derived: sum of 4 quarters · filed 2017-03-08 | |
| 2015-03-31 | -$9.16M 10-K · filed 2017-03-08 | -$4.22M 10-Q · filed 2015-05-12 | -$7.93M derived: sum of 2 quarters · filed 2017-03-08 | $1.26M derived: sum of 3 quarters · filed 2017-03-08 | $2.49M derived: sum of 4 quarters · filed 2017-03-08 |
| 2014-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $10.41M derived: sum of 2 quarters · filed 2017-03-08 | $11.64M derived: sum of 3 quarters · filed 2017-03-08 | $13.02M 10-K · filed 2017-03-08 | |
| 2014-09-30 | $9.19M 10-Q · filed 2015-11-10 | $10.42M derived: sum of 2 quarters · filed 2015-11-10 | $11.79M 10-Q · filed 2015-11-10 | $14.31M derived: sum of 4 quarters · filed 2016-03-08 | |
| 2014-06-30 | $1.23M 10-Q · filed 2015-08-13 | $2.60M 10-Q · filed 2015-08-13 | $5.12M derived: sum of 3 quarters · filed 2016-03-08 | $11.49M derived: sum of 4 quarters · filed 2016-03-08 | |
| 2014-03-31 | $1.37M 10-Q/A · filed 2015-08-13 | $3.89M derived: sum of 2 quarters · filed 2016-03-08 | $10.27M derived: sum of 3 quarters · filed 2016-03-08 | ||
| 2013-12-31 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $8.89M derived: sum of 2 quarters · filed 2016-03-08 | $12.03M 10-K · filed 2016-03-08 | ||
| 2013-09-30 | $6.38M 10-Q · filed 2014-12-15 | $9.52M 10-Q · filed 2014-12-15 | |||
| 2012-12-31 | -$4.30M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |